Short Interest in Aterian, Inc. (NASDAQ:ATER) Declines By 18.1%

Aterian, Inc. (NASDAQ:ATER) was the target of a significant decrease in short interest in the month of August. As of August 31st, there was short interest totalling 300,500 shares, a decrease of 18.1% from the August 15th total of 367,000 shares. Approximately 4.6% of the company’s shares are short sold. Based on an average daily trading volume, of 119,600 shares, the short-interest ratio is currently 2.5 days.

Aterian Trading Up 0.3 %

Shares of NASDAQ:ATER opened at $3.18 on Wednesday. The company has a 50-day moving average price of $3.02 and a 200-day moving average price of $2.93. The company has a market cap of $27.28 million, a price-to-earnings ratio of -0.38 and a beta of 2.04. Aterian has a 12 month low of $1.90 and a 12 month high of $6.54.

Aterian (NASDAQ:ATER) last announced its quarterly earnings results on Thursday, August 8th. The company reported ($0.52) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.64) by $0.12. Aterian had a negative return on equity of 64.24% and a negative net margin of 18.88%. The company had revenue of $27.98 million for the quarter.

Insider Buying and Selling at Aterian

In other news, Director William Kurtz sold 8,547 shares of Aterian stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $3.01, for a total value of $25,726.47. Following the transaction, the director now owns 47,216 shares in the company, valued at $142,120.16. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In other news, Director William Kurtz sold 8,547 shares of the stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $3.01, for a total transaction of $25,726.47. Following the completion of the sale, the director now owns 47,216 shares of the company’s stock, valued at $142,120.16. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CTO Roi Zion Zahut sold 14,050 shares of Aterian stock in a transaction on Wednesday, September 11th. The stock was sold at an average price of $3.06, for a total transaction of $42,993.00. Following the completion of the transaction, the chief technology officer now directly owns 201,494 shares in the company, valued at $616,571.64. The disclosure for this sale can be found here. Insiders sold a total of 49,015 shares of company stock worth $150,562 over the last three months. Company insiders own 4.70% of the company’s stock.

Hedge Funds Weigh In On Aterian

An institutional investor recently bought a new position in Aterian stock. XTX Topco Ltd acquired a new stake in shares of Aterian, Inc. (NASDAQ:ATER) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 20,974 shares of the company’s stock, valued at approximately $59,000. XTX Topco Ltd owned 0.24% of Aterian at the end of the most recent quarter. 7.02% of the stock is currently owned by institutional investors and hedge funds.

About Aterian

Aterian, Inc, together with its subsidiaries, operates as a technology-enabled consumer products company in North America and internationally. Its platform offers home and kitchen appliances; kitchenware; cooling and air quality appliances, such as dehumidifiers; health and beauty products; and essential oils under the Squatty Potty, hOmeLabs, Mueller, Pursteam, Healing Solutions, and Photo Paper Direct brand names.